Literature DB >> 861451

The effect of radiation on tumour growth delay, cell survival and cure of the animal using a single tumour system.

N J McNally, P W Sheldon.   

Abstract

The response of a murine tumour to single doses of X rays has been measured using three different assays--animal cure, cell survival in vitro after irradiation in vivo, and tumour growth delay. The dose to cure 50% of the animals, the TCD50, was 79.0 Gy. This was not affected by clamping the tumours to render all the cells hypoxic at the time of irradiation, implying that most of the cells in the tumour were hypoxic already. The enhancement ratio for the hypoxic cell sensitizer Ro-07-0582 was 2.1. The cell survival assay gave an enhancement ratio of 1.6 and an hypoxic fraction of 5%. The discrepancy in the estimates of the hypoxic fraction can be explained by the ability of the naturally hypoxic cells, but not the oxic ones, to recover from potentially lethal damage in vivo. Neither the cell survival assay nor the growth delay assay agreed with the TCD50 assay as to the effect of the hypoxic cell sensitizer, even allowing for recovery from potentially lethal damage. It is doubtful whether the measured survival curve would predict the measured TCD50.

Entities:  

Mesh:

Year:  1977        PMID: 861451     DOI: 10.1259/0007-1285-50-593-321

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  10 in total

1.  Temperature dependent modification of radiosensitivity following hypoxic cytocidal action of chlorpromazine.

Authors:  M A Shenoy; B B Singh
Journal:  Radiat Environ Biophys       Date:  1985       Impact factor: 1.925

2.  Further investigations of the effects of the hypoxic-cell radiosensitizer, Ro-07-0582, on local control of a mouse tumour.

Authors:  P W Sheldon; S A Hill
Journal:  Br J Cancer       Date:  1977-08       Impact factor: 7.640

Review 3.  Tumor hypoxia: its impact on cancer therapy.

Authors:  J E Moulder; S Rockwell
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

Review 4.  Can dose-survival parameters be deduced from in situ assays?

Authors:  T E Wheldon
Journal:  Br J Cancer Suppl       Date:  1980-04

5.  Effect of tumor dissaggregation on results of in vitro cell survival assay after in vivo treatment of the EMT-6 tumor: x-rays, cyclophosphamide, and bleomycin.

Authors:  J S Rasey; N J Nelson
Journal:  In Vitro       Date:  1980-07

6.  Radiosensitization by misonidazole (Ro-07-0582) of fractionated X-rays in a murine tumour.

Authors:  P W Sheldon; J F Fowler
Journal:  Br J Cancer Suppl       Date:  1978-06

7.  Radiobiological studies of tumours in situ compared with cell survival.

Authors:  N J McNally; J de Ronde
Journal:  Br J Cancer Suppl       Date:  1980-04

8.  Regression, recurrence and cure in an irradiated mouse tumour.

Authors:  A S Abdelaal; A H Nias
Journal:  J R Soc Med       Date:  1979-02       Impact factor: 18.000

9.  Potentiation of melphalan activity against a murine tumour by nitroimidazole compounds.

Authors:  P W Sheldon; E L Batten; G E Adams
Journal:  Br J Cancer       Date:  1982-10       Impact factor: 7.640

10.  Potentiation of the anti-tumour effect of melphalan by the vasoactive agent, hydralazine.

Authors:  I J Stratford; G E Adams; J Godden; J Nolan; N Howells; N Timpson
Journal:  Br J Cancer       Date:  1988-08       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.